These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 12474226)

  • 61. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 62. No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer.
    Otto W; Denzinger S; Bertz S; Gaumann A; Wild PJ; Hartmann A; Stoehr R
    Int J Cancer; 2009 Nov; 125(9):2205-8. PubMed ID: 19621447
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinical value of aneusomy of chromosomes in exfoliated urothelial cells to predict the recurrence of superficial bladder cancer after complete transurethral resection].
    Bao QB; Liu J; Sun HB; Su JH; Zhu JG; Lin JZ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):548-51. PubMed ID: 19567078
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.
    Denzinger S; Stoehr R; Schwarz S; Eichenseher N; Brockhoff G; Obermann EC; Knuechel R; Blaszyk H; Hartmann A; Wild PJ
    Int J Oncol; 2007 Oct; 31(4):793-802. PubMed ID: 17786310
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization.
    Voorter C; Joos S; Bringuier PP; Vallinga M; Poddighe P; Schalken J; du Manoir S; Ramaekers F; Lichter P; Hopman A
    Am J Pathol; 1995 Jun; 146(6):1341-54. PubMed ID: 7778674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.
    Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ
    J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization.
    Tsuda H; Takarabe T; Susumu N; Inazawa J; Okada S; Hirohashi S
    Am J Pathol; 1997 Oct; 151(4):1027-34. PubMed ID: 9327736
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genomic imbalances in urothelial cancer: intratumor heterogeneity versus multifocality.
    Prat E; Del Rey J; Camps J; Ponsa I; Lloreta J; Egozcue J; Gelabert A; Campillo M; Miro R
    Diagn Mol Pathol; 2008 Sep; 17(3):134-40. PubMed ID: 18382360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
    Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
    Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.
    Hirao S; Hirao T; Marsit CJ; Hirao Y; Schned A; Devi-Ashok T; Nelson HH; Andrew A; Karagas MR; Kelsey KT
    Cancer; 2005 Nov; 104(9):1918-23. PubMed ID: 16149093
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms.
    Fujii H; Ajioka Y; Kazami S; Takagaki T; Gong Zhu X; Hirose S; Watanabe H; Shirai T
    J Pathol; 2002 Jul; 197(3):298-306. PubMed ID: 12115875
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.
    Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA
    Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853
    [TBL] [Abstract][Full Text] [Related]  

  • 73. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
    van der Kwast TH
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.
    Orlow I; Lianes P; Lacombe L; Dalbagni G; Reuter VE; Cordon-Cardo C
    Cancer Res; 1994 Jun; 54(11):2848-51. PubMed ID: 8187066
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC).
    Chapman EJ; Williams SV; Platt FM; Hurst CD; Chambers P; Roberts P; Knowles MA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):694-710. PubMed ID: 19405089
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Significance of denuded urothelium in papillary urothelial lesions.
    Owens CL; Epstein JI
    Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.
    Cairns P; Proctor AJ; Knowles MA
    Oncogene; 1991 Dec; 6(12):2305-9. PubMed ID: 1766677
    [TBL] [Abstract][Full Text] [Related]  

  • 78. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas.
    Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
    J Urol; 2005 Jan; 173(1):243-6. PubMed ID: 15592089
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.
    McCarthy RP; Wang M; Jones TD; Strate RW; Cheng L
    Clin Cancer Res; 2006 Apr; 12(8):2414-8. PubMed ID: 16638846
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci.
    Habuchi T; Devlin J; Elder PA; Knowles MA
    Oncogene; 1995 Oct; 11(8):1671-4. PubMed ID: 7478593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.